H.C. Wainwright analyst Douglas Tsao lowered the firm’s price target on Outlook Therapeutics (OTLK) to $3 from $30 and keeps a Buy rating on ...
NetScout Systems, Inc. is undervalued despite its strong positioning in network performance, cybersecurity, and cloud ...